dacomitinib (vizimpro) Report issue

Small molecule Orphan Drug FDA Approved FDA Priority Review FDA
AACT ChEMBL DrugBank Drugs@FDA MeSH PubChem
Back

Drug Pricing Summary

VA Big4

$292.0620 - $302.4840

VA FSS

$404.2573

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
dacomitinib 15 mg (TABLET) $299.5443 VA Big4
  • Vizimpro (30)
    		•  Pfizer, Inc.
    dacomitinib 15 mg (TABLET) $404.2573 VA FSS
  • Vizimpro (30)
    		•  Pfizer, Inc.
    dacomitinib 30 mg (TABLET) $302.4840 VA Big4
  • Vizimpro (30)
    		•  Pfizer, Inc.
    dacomitinib 30 mg (TABLET) $404.2573 VA FSS
  • Vizimpro (30)
    		•  Pfizer, Inc.
    dacomitinib 45 mg (TABLET) $292.0620 VA Big4
  • Vizimpro (30)
    		•  Pfizer, Inc.
    dacomitinib 45 mg (TABLET) $404.2573 VA FSS
  • Vizimpro (30)
    		•  Pfizer, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue